Dlbcl - Diffuse Large B Cell Lymphoma Clinical Trials
3 recruiting trials for Dlbcl - Diffuse Large B Cell Lymphoma. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Dlbcl - Diffuse Large B Cell Lymphoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Memorial Sloan Kettering Cancer Center (1), University Medical Center Groningen (1), Ain Shams University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cerebral Spinal Fluid ctDNA (diagnostic_test, 1 trial), followed by ARI-0001, Axi-cel.
Track Dlbcl - Diffuse Large B Cell Lymphoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
The purpose of this study is to find out how many people with B-cell lymphoma who are at high risk for central nervous system/CNS relapse test positive for cerebral spinal...
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
A phase II, multi-center study to compare the feasibility, and clinical efficacy of local manufacturing of CD19-directed CAR T-cells (ARI-0001 CAR T-cells) with commercial...
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
This observational study evaluates the predictive value of systemic inflammatory markers-CRP, albumin, CRP-to-albumin ratio (CAR), and modified Glasgow Prognostic Score (mGPS)-in...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Dlbcl - Diffuse Large B Cell Lymphoma, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Dlbcl - Diffuse Large B Cell Lymphoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Dlbcl - Diffuse Large B Cell Lymphoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.